Active	Status	Sponsor type	Region	Phase	Filter
3 Active 2 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
ganaxolone IV / Marinus
RAISE, NCT04391569: Randomized Therapy In Status Epilepticus	Completed	3	124	Canada, US, RoW	Ganaxolone, Placebo	Marinus Pharmaceuticals	Status Epilepticus	03/24	04/24
NCT05814523: To Evaluate the Efficacy, Safety, and Tolerability of Intravenous Ganaxolone Added to Standard of Care in Refractory Status Epilepticus (RSE)	Withdrawn	3	70	Europe, RoW	Ganaxolone, Placebo, Standard of care	Marinus Pharmaceuticals	Refractory Status Epilepticus	08/24	08/24
NCT05757544: Safety and Efficacy Study of IV Ganaxolone as Adjuvant Therapy for Established Status Epilepticus (ESE)	Withdrawn	2	120	NA	IV Ganaxolone, IV Placebo	Marinus Pharmaceuticals	Status Epilepticus	02/26	02/26